
Adaptive Biotechnologies: Good Buy For Long-Term Investors (ADPT)
designer491/iStock via Getty Images Investment Thesis Adaptive Biotechnologies Corp. (NASDAQ:ADPT) stock is down over 72% in the previous 52-weeks and 58.5% YTD. Since its inception, the company has been a loss-maker. Still, the revenues have […]